Search Results - polly+matzinger

2 Results Sort By:
Identification of Candidate Ligands which Modulate Antigen Presenting Cells
Available for licensing and commercial development are novel biotechnological tools, prophylactics, therapeutics, and methods for modulating the activation state of an antigen presenting cell (APC) and thereby modulating the activation of a killer T cell. The activation of a killer T cell can occur in a two cell complex and two sequential steps: a)...
Published: 10/28/2024   |   Inventor(s): Polly Matzinger, John Ridge
Keywords(s): CB6XXX, CBXXXX, CXXXXX, DB4XXX, DBXXXX, DC5XXX, DCXXXX, DXXXXX, IB3XXX, IBXXXX, IXXXXX
Category(s): Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Immunology, Application > Diagnostics, Application > Research Materials, Application > Therapeutics, Application > Vaccines, TherapeuticArea > Oncology, TherapeuticArea > Infectious Disease
Oral Treatment of Hemophilia
This invention portrays a simple method for treatment of antigen-deficiency diseases by orally administering to a subject a therapeutically effective amount of the deficient antigen, wherein the antigen is not present in a liposome. This method increases hemostasis in a subject having hemophilia A or B, by orally administering to the hemophiliac a...
Published: 10/28/2024   |   Inventor(s): Oral Alpan, Polly Matzinger, Tirumalai Kamala, William Velander
Keywords(s): 3-@hydroxyacyl-coa dehydrogenase deficiency, HAD deficiency, Hemophilia A, Hemophilia B, HIS deficiency, Histidinemia, IBXXXX, IXXXXX, VPXXXX, WJXXXX, YBXXXX, YCXXXX
Category(s): Collaboration Sought > Licensing, TherapeuticArea > Infectious Disease, TherapeuticArea > Dental, TherapeuticArea > Oncology, Application > Diagnostics, TherapeuticArea > Endocrinology, TherapeuticArea > Ophthalmology, Application > Therapeutics, Application > Research Materials, TherapeuticArea > Cardiology